SANUWAVE Health, Inc. (SNWV) earnings
SNWV earnings moved a median of -0.07% by the close. Quarterly and annual SNWV reports and results, each read against the price at its own news timestamp. Back to the SNWV overview →
19 measured SNWV earnings events.
Where these SNWV earnings landedvs 19 measured SNWV earnings reactions
| Middle 50% of SNWV earnings reactions | -6.27% to +5.78% |
|---|---|
| Median reaction (to close) | -0.07% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 SNWV earnings events with a measured close landed between -6.27% and +5.78%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q SANUWAVE Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.97% | -1.01% | |
| Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance | Press release | -10.74% | -8.00% | |
| Sanuwave Health Updates Second Quarter 2026 Guidance | Press release | -5.63% | -14.47% | |
| Form 10-Q SANUWAVE Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | +12.01% | +12.07% | |
| Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year | Press release | +0.00% | +11.89% | |
| Form 10-K SANUWAVE Health, Inc. For: Dec 31 | SEC filing · Form 10-K | +15.75% | +11.04% | |
| Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue | Press release | +1.61% | -0.07% | |
| Form 10-Q SANUWAVE Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.90% | +3.60% | |
| Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) | Press release | -0.76% | +1.62% | |
| Form 10-Q SANUWAVE Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.48% | +4.80% | |
| Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025) | Press release | +0.00% | -7.22% | |
| Form 10-Q SANUWAVE Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -4.60% | |
| SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025) | Press release | +0.03% | -0.84% | |
| Form 10-K SANUWAVE Health, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.91% | +12.64% | |
| Form 10-Q SANUWAVE Health, Inc. For: Jun 30 | SEC filing · Form 10-Q | -11.18% | -5.88% | |
| Form 10-Q SANUWAVE Health, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.78% | |
| SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) | Press release | +0.00% | -35.91% | |
| Form 10-K SANUWAVE Health, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.87% | +6.76% | |
| Form 10-Q SANUWAVE Health, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -6.67% |
Keep exploring
More SNWV: analyst actions → · SEC filings → · SNWV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Dyadic International, Inc. (DYAI) | 232 | 0.00% | 45% |
| Omeros Corporation (OMER) | 232 | +0.49% | 57% |
| Bio-Rad Laboratories, Inc. Class A (BIO) | 231 | -0.06% | 46% |
| Cronos Group Inc. - Common Share (CRON) | 230 | +0.27% | 62% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.